Jonathan I. Epstein
American pathologist and researcher
Jonathan I. Epstein is an American pathologist and researcher known for his contributions to the field of urologic pathology, particularly in the study of prostate cancer. He is a professor at Johns Hopkins University and has published extensively on the diagnosis and treatment of prostate cancer.
Education[edit | edit source]
Epstein received his medical degree from Harvard Medical School. He completed his residency in pathology at Johns Hopkins Hospital, where he also completed a fellowship in urologic pathology.
Career[edit | edit source]
Epstein has spent the majority of his career at Johns Hopkins University, where he has held various academic and administrative positions. He is currently the Director of Surgical Pathology and the Director of the Division of Urologic Pathology at Johns Hopkins Hospital.
Research[edit | edit source]
Epstein's research has focused on the pathology of prostate cancer, including the development of diagnostic criteria and grading systems. He has authored numerous articles and book chapters on the subject and is considered a leading expert in the field.
Publications[edit | edit source]
Epstein has published over 500 peer-reviewed articles and several books on urologic pathology. His work is widely cited in the medical community, and he has contributed to the development of guidelines for the diagnosis and treatment of prostate cancer.
Awards and Honors[edit | edit source]
Throughout his career, Epstein has received numerous awards for his contributions to pathology and medical research. He is a member of several professional organizations, including the American Association for Cancer Research and the College of American Pathologists.
Personal Life[edit | edit source]
Epstein resides in Baltimore, Maryland, where he continues to work at Johns Hopkins University.
See also[edit | edit source]
References[edit | edit source]
 | This hospital-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
